Abstract:International Journal of Laboratory HematologyEarly View LETTER TO THE EDITOR Prognostic value of post-transplantation Wilms' tumor gene 1 expression in acute myeloid leukaemia subgroup according to different pre-transplant disease status Ke Wang, Ke Wang Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXin-Xin Liu, Xin-Xin Liu Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China Beijing Hightrust Diagnostics, Co., Ltd, Beijing, ChinaSearch for more papers by this authorYa-Zhen Qin, Ya-Zhen Qin orcid.org/0000-0002-1548-0946 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorYing-Jun Chang, Ying-Jun Chang orcid.org/0000-0002-6124-6050 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorYu-Qian Sun, Yu-Qian Sun Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorChen-Hua Yan, Chen-Hua Yan Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorYu Wang, Yu Wang Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXiao-Hui Zhang, Xiao-Hui Zhang Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXiao-Jun Huang, Xiao-Jun Huang Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China Beijing Hightrust Diagnostics, Co., Ltd, Beijing, China Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China Collaborative Innovation Center of Hematology, Peking University, Beijing, China Peking-Tsinghua Center for Life Sciences, Beijing, ChinaSearch for more papers by this authorXiao-Su Zhao, Corresponding Author Xiao-Su Zhao zhao.xiaosu@outlook.com orcid.org/0000-0001-7749-8087 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China Collaborative Innovation Center of Hematology, Peking University, Beijing, China Correspondence Xiao-Su Zhao, No. 11 Xizhimen South Street, Xicheng District, Beijing, China. Email: zhao.xiaosu@outlook.comSearch for more papers by this author Ke Wang, Ke Wang Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXin-Xin Liu, Xin-Xin Liu Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China Beijing Hightrust Diagnostics, Co., Ltd, Beijing, ChinaSearch for more papers by this authorYa-Zhen Qin, Ya-Zhen Qin orcid.org/0000-0002-1548-0946 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorYing-Jun Chang, Ying-Jun Chang orcid.org/0000-0002-6124-6050 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorYu-Qian Sun, Yu-Qian Sun Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorChen-Hua Yan, Chen-Hua Yan Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorYu Wang, Yu Wang Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXiao-Hui Zhang, Xiao-Hui Zhang Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXiao-Jun Huang, Xiao-Jun Huang Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China Beijing Hightrust Diagnostics, Co., Ltd, Beijing, China Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China Collaborative Innovation Center of Hematology, Peking University, Beijing, China Peking-Tsinghua Center for Life Sciences, Beijing, ChinaSearch for more papers by this authorXiao-Su Zhao, Corresponding Author Xiao-Su Zhao zhao.xiaosu@outlook.com orcid.org/0000-0001-7749-8087 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China Collaborative Innovation Center of Hematology, Peking University, Beijing, China Correspondence Xiao-Su Zhao, No. 11 Xizhimen South Street, Xicheng District, Beijing, China. Email: zhao.xiaosu@outlook.comSearch for more papers by this author First published: 01 July 2022 https://doi.org/10.1111/ijlh.13924 Ke Wang and Xin-Xin Liu contributed equally to this work. Funding information: CAMS Innovation Fund for Medical Science, Grant/Award Number: 2019-12M-5-034; Innovative Research Groups of the National Natural Science Foundation of China, Grant/Award Number: 81621001; National Natural Science Foundation of China, Grant/Award Number: 81870137; National Key Research and Development Program of China, Grant/Award Number: 2021YFC2500300 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Early ViewOnline Version of Record before inclusion in an issue RelatedInformation

Abstract:International Journal of Laboratory HematologyEarly View LETTER TO THE EDITOR Identification and clinical implications of recurrent PAX5::MLLT3 fusion in lymphoid blastic phase chronic myeloid leukemia Lijun Wang, Lijun Wang orcid.org/0009-0003-8270-4633 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorYu Chen, Yu Chen orcid.org/0000-0001-9933-8869 Department of Hematology, The Second Affiliated Hospital of Wannan Medical College, Wuhu, ChinaSearch for more papers by this authorQingyuan Wang, Qingyuan Wang National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorMeng Xiang, Meng Xiang National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorZhao Zeng, Zhao Zeng National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorZhibo Zhang, Zhibo Zhang National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorFenghong Zhang, Fenghong Zhang orcid.org/0000-0001-5468-6341 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorSuning Chen, Corresponding Author Suning Chen [email protected] National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China Correspondence Suning Chen and Mengxing Xue, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Shizi Street 188, Suzhou 215006, China. Email: [email protected] and [email protected]Search for more papers by this authorMengxing Xue, Corresponding Author Mengxing Xue [email protected] National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China Correspondence Suning Chen and Mengxing Xue, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Shizi Street 188, Suzhou 215006, China. Email: [email protected] and [email protected]Search for more papers by this author Lijun Wang, Lijun Wang orcid.org/0009-0003-8270-4633 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorYu Chen, Yu Chen orcid.org/0000-0001-9933-8869 Department of Hematology, The Second Affiliated Hospital of Wannan Medical College, Wuhu, ChinaSearch for more papers by this authorQingyuan Wang, Qingyuan Wang National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorMeng Xiang, Meng Xiang National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorZhao Zeng, Zhao Zeng National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorZhibo Zhang, Zhibo Zhang National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorFenghong Zhang, Fenghong Zhang orcid.org/0000-0001-5468-6341 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaSearch for more papers by this authorSuning Chen, Corresponding Author Suning Chen [email protected] National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China Correspondence Suning Chen and Mengxing Xue, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Shizi Street 188, Suzhou 215006, China. Email: [email protected] and [email protected]Search for more papers by this authorMengxing Xue, Corresponding Author Mengxing Xue [email protected] National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China Correspondence Suning Chen and Mengxing Xue, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Shizi Street 188, Suzhou 215006, China. Email: [email protected] and [email protected]Search for more papers by this author First published: 23 February 2024 https://doi.org/10.1111/ijlh.14245 Lijun Wang, Yu Chen, and Qingyuan Wang contributed equally to this work. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Open Research DATA AVAILABILITY STATEMENT The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Supporting Information Filename Description ijlh14245-sup-0001-Tables.xlsxExcel 2007 spreadsheet , 53.1 KB Supplementary Table 1 The result of RNA sequencing for PAX5-MLLT3 fusion gene. Supplementary Table 2 Clinical characteristics of four patients of PAX5-MLLT3 fusion genes. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. REFERENCES 1Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Am J Hematol. 2022; 97: 1236-1256. doi:10.1002/ajh.26642 10.1002/ajh.26642 CASPubMedWeb of Science®Google Scholar 2Krishnan V, Kim DDH, Hughes TP, Branford S, Ong ST. Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers. Haematologica. 2022; 107: 358-370. doi:10.3324/haematol.2021.279317 10.3324/haematol.2021.279317 CASPubMedGoogle Scholar 3Cobaleda C, Schebesta A, Delogu A, Busslinger M. Pax5: the guardian of B cell identity and function. Nat Immunol. 2007; 8: 463-470. 10.1038/ni1454 CASPubMedWeb of Science®Google Scholar 4Schinnerl D, Fortschegger K, Kauer M, et al. The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia. Blood. 2015; 125: 1282-1291. doi:10.1182/blood-2014-04-570960 10.1182/blood-2014-04-570960 CASPubMedWeb of Science®Google Scholar 5Coyaud E, Struski S, Prade N, et al. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. Blood. 2010; 115: 3089-3097. doi:10.1182/blood-2009-07-234229 10.1182/blood-2009-07-234229 CASPubMedWeb of Science®Google Scholar 6Kurahashi S, Hayakawa F, Miyata Y, et al. PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML. Oncogene. 2011; 30: 1822-1830. doi:10.1038/onc.2010.554 10.1038/onc.2010.554 CASPubMedWeb of Science®Google Scholar 7Calvanese V, Nguyen AT, Bolan TJ, et al. MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature. 2019; 576: 281-286. doi:10.1038/s41586-019-1790-2 10.1038/s41586-019-1790-2 CASPubMedWeb of Science®Google Scholar 8Bernt KM, Zhu N, Sinha AU, et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell. 2011; 20: 66-78. doi:10.1016/j.ccr.2011.06.010 10.1016/j.ccr.2011.06.010 CASPubMedWeb of Science®Google Scholar 9Lee S-T, Ji Y, Kim H-J, et al. Sequential array comparative genomic hybridization analysis identifies copy number changes during blastic transformation of chronic myeloid leukemia. Leuk Res. 2012; 36: 418-421. doi:10.1016/j.leukres.2011.12.021 10.1016/j.leukres.2011.12.021 CASPubMedGoogle Scholar 10Sill H, Goldman JM, Cross NC. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood. 1995; 85: 2013-2016. 10.1182/blood.V85.8.2013.bloodjournal8582013 CASPubMedWeb of Science®Google Scholar 11Liu Y-F, Wang B-Y, Zhang W-N, et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016; 8: 173-183. doi:10.1016/j.ebiom.2016.04.038 10.1016/j.ebiom.2016.04.038 PubMedWeb of Science®Google Scholar 12Fazio G, Daniele G, Cazzaniga V, et al. Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2015; 100: e14-e17. doi:10.3324/haematol.2014.112193 10.3324/haematol.2014.112193 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation

Extramedullary T‐lymphoblastic Blast Crisis in Chronic Myeloid Leukemia: A Very Rare Case Associated with Comutation of ABL1 T315I and H396R

Trisomy 21 in Patients with Acute Leukemia

Identification and Lineage Restriction Analyses of Preleukemia Cells in a Sporadic Biallelic CEBPA Mutated Acute Myeloid Leukemia Patient

Extramedullary blast crisis of CD 34 + CD 38-leukemia stem cells in chronic myeloid leukemia resistant to tyrosine kinase inhibitors : a report of two cases

Clonal Evolution of AML1-ETO Coexisting with BCR-ABL and Additional Chromosome Abnormalities in a Blastic Transformation of Chronic Myeloid Leukemia

Bilineal Extramedullary Blast Crisis As an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review

Early T‐cell Precursor Acute Lymphoblastic Leukemia with Auer Rods in Mature Granulocytes

Extramedullary T-Lymphoblastic Blast Crisis in Chronic Myelogenous Leukemia: A Case Report of Successful Diagnosis and Treatment

Integrated Transcriptomic And Epigenetic Data Analysis Identifies Aberrant Expression Of Genes In Acute Myeloid Leukemia With Mll-Af9 Translocation (Vol 21, Pg 883, 2020)

Prognostic Value of Post-Transplantation Wilms' Tumor Gene 1 Expression in Acute Myeloid Leukaemia Subgroup According to Different Pre-Transplant Disease Status

ABO Gene Mutation C.815_816insg in an African Individual Forms a Novel Ael Allele

A Subset of CD20+ MM Patients Without the T(11;14) Are Associated with Poor Prognosis and a Link to Aberrant Expression of Wnt Signaling

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

Successful Chemotherapy for a Case of Therapy-Related ALL Withmllgene Rearrangement Following Treatment of Breast Cancer

Poster: ALL-144: Oncogenic Deregulation of BCL11B in Lineage Ambiguous Leukemia

Sudden Extramedullary Blast Crisis of Chronic Myeloid Leukemia Manifesting As T-cell Lymphoblastic Lymphoma.

Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia

Identification and Clinical Implications of Recurrent PAX5::MLLT3 Fusion in Lymphoid Blastic Phase Chronic Myeloid Leukemia

Extramedullary Blast Crisis in a Patient with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.

Cmar_a_199817 3187..3196

T lymphoblastic lymphoma/acute lymphoblastic leukemia from blast crisis of chronic myelogenous leukemia—A case report and the review of literature